TY - GEN
T1 - Cobalamin restriction with AIN-93M chow modification
T2 - 3rd International Symposium of Biomedical Engineering''s Recent Progress in Biomaterials, Drugs Development, and Medical Devices, ISBE 2018
AU - Amani, Patwa
AU - Prijanti, Ani Retno
AU - Jusuf, Ahmad Aulia
AU - Kartinah, Neng Tine
AU - Ujianti, Irena
AU - Murthi, Aditya Krishna
AU - Soeria, Dewi Irawati
N1 - Publisher Copyright:
© 2019 Author(s).
PY - 2019/4/9
Y1 - 2019/4/9
N2 -
The correlation between cobalamin deficiency and anemia has been studied extensively. However, the effect of cobalamin deficiency on cardiovascular conditions has not been fully understood yet. Our study was conducted to explore the possible cardiovascular function alteration in anemia condition after cobalamin restriction diet. Eighteen adult male Sprague-Dawley rat were randomly divided into three groups: (a) control group were fed with standard AIN-93M diet for 12 weeks (Co); (b) The 1
st
treatment group was fed with cobalamin restricted AIN-93M diet for 4 weeks (R4); and (c) The 2
nd
treatment group was fed with cobalamin restricted AIN-93M diet for 12 weeks (R12). The cobalamin restricted chow defined as the modification of the standard AIN-93M with omitting cobalamin and adding 5% pectin to each kilogram of chow. The level of cobalamin, hematocrit, hemoglobin, erythrocyte and BNP were measured before and after feeding procedure. Hematology parameters were measured with Sysmex hematology analyzers, while plasma cobalamin and BNP level were measured with ELISA kit provided by MyBiosource. Plasma cobalamin level decreased about 102.84 pg/ml in R4 group and 189.53 pg/ml in R12 group compared to their initial level. Meanwhile, it remained stable in control group. The hemoglobin, hematocrit, and erythrocyte level decreased in the R4 group and R12 group, but only significant in the R12 group. The BNP plasma level increased in all groups but not statistically significant. The administration of cobalamin restricted chow in rats decreased plasma cobalamin level, resulting in hematological and cardiovascular parameter alteration.
AB -
The correlation between cobalamin deficiency and anemia has been studied extensively. However, the effect of cobalamin deficiency on cardiovascular conditions has not been fully understood yet. Our study was conducted to explore the possible cardiovascular function alteration in anemia condition after cobalamin restriction diet. Eighteen adult male Sprague-Dawley rat were randomly divided into three groups: (a) control group were fed with standard AIN-93M diet for 12 weeks (Co); (b) The 1
st
treatment group was fed with cobalamin restricted AIN-93M diet for 4 weeks (R4); and (c) The 2
nd
treatment group was fed with cobalamin restricted AIN-93M diet for 12 weeks (R12). The cobalamin restricted chow defined as the modification of the standard AIN-93M with omitting cobalamin and adding 5% pectin to each kilogram of chow. The level of cobalamin, hematocrit, hemoglobin, erythrocyte and BNP were measured before and after feeding procedure. Hematology parameters were measured with Sysmex hematology analyzers, while plasma cobalamin and BNP level were measured with ELISA kit provided by MyBiosource. Plasma cobalamin level decreased about 102.84 pg/ml in R4 group and 189.53 pg/ml in R12 group compared to their initial level. Meanwhile, it remained stable in control group. The hemoglobin, hematocrit, and erythrocyte level decreased in the R4 group and R12 group, but only significant in the R12 group. The BNP plasma level increased in all groups but not statistically significant. The administration of cobalamin restricted chow in rats decreased plasma cobalamin level, resulting in hematological and cardiovascular parameter alteration.
KW - AIN-93M
KW - anemia
KW - brain natriuretic peptide
KW - cobalamin
UR - http://www.scopus.com/inward/record.url?scp=85064816011&partnerID=8YFLogxK
U2 - 10.1063/1.5096741
DO - 10.1063/1.5096741
M3 - Conference contribution
AN - SCOPUS:85064816011
T3 - AIP Conference Proceedings
BT - 3rd Biomedical Engineering''s Recent Progress in Biomaterials, Drugs Development, and Medical Devices
A2 - Wulan, Praswasti P.D.K.
A2 - Gozan, Misri
A2 - Astutiningsih, Sotya
A2 - Ramahdita, Ghiska
A2 - Dhelika, Radon
A2 - Kreshanti, Prasetyanugraheni
PB - American Institute of Physics Inc.
Y2 - 6 August 2018 through 8 August 2018
ER -